Last reviewed · How we verify
Suzhou Abogen Biosciences Co., Ltd. — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
3 Phase 2
2 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Oncology · 2
- Diabetes · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Beijing Tiantan Hospital · 2 shared drug classes
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · 2 shared drug classes
- Ahn-Gook Pharmaceuticals Co.,Ltd · 2 shared drug classes
- Asan Medical Center · 2 shared drug classes
- BioRay Pharmaceutical Co., Ltd. · 2 shared drug classes
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · 2 shared drug classes
- Addpharma Inc. · 2 shared drug classes
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · 2 shared drug classes
Subscribe to ongoing alerts
Every new pipeline event for Suzhou Abogen Biosciences Co., Ltd.:
- Suzhou Abogen Biosciences Co., Ltd. pipeline updates — RSS
- Suzhou Abogen Biosciences Co., Ltd. pipeline updates — Atom
- Suzhou Abogen Biosciences Co., Ltd. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Suzhou Abogen Biosciences Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/suzhou-abogen-biosciences-co-ltd. Accessed 2026-05-17.